Paosonelle (Drospirenone, Estradiol Hemihydrate)

Paosonelle is a combined oral contraceptive that acts on the hormonal regulation pathway to prevent ovulation.

• Contraception: Provides reliable prevention of pregnancy when taken as prescribed.
• Menstrual Cycle Regulation: Helps establish a more predictable menstrual cycle.
• Acne Management: Reduces acne severity linked to hormonal fluctuations.

• Drospirenone is a synthetic progestogen with anti‑mineralocorticoid and anti‑androgenic activity, while estradiol hemihydrate supplies estrogenic support. Together they suppress the hypothalamic‑pituitary‑ovarian axis, inhibiting the luteinizing hormone surge and preventing follicular development, which stops ovulation. The estrogen component stabilises the endometrium and maintains cycle control.

Adverse reactions to Paosonelle vary in frequency and severity.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Headache: tension‑type or migraine‑like pain.
• Breast tenderness: temporary swelling or discomfort.
• Weight gain: mild fluid retention.
• Mood changes: irritability or emotional lability.
• Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects

• Deep vein thrombosis: blood clot formation in deep veins.
• Pulmonary embolism: clot migration to lung vessels.
• Stroke: cerebrovascular accident due to clot or hemorrhage.
• Myocardial infarction: heart attack risk, especially in smokers.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Liver dysfunction: jaundice or abnormal liver enzymes.

Before prescribing Paosonelle, clinicians should assess individual risk factors and contraindications.

• Smoking status: avoid in women >35 who smoke due to thrombotic risk.
• Cardiovascular history: assess for hypertension, clotting disorders, or prior stroke.
• Liver function: evaluate for active liver disease.
• Migraine history: caution in patients with migraine with aura.
• Cancer history: avoid in estrogen‑sensitive malignancies.
• Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture.

Paosonelle may interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Enzyme inducers (e.g., rifampicin, carbamazepine): reduced contraceptive effectiveness.
• Antiretrovirals (e.g., efavirenz): may lower hormone levels.

Moderate Interactions (Monitor Closely)

• Antifungals (e.g., fluconazole): possible increased hormone exposure.
• Antidepressants (e.g., sertraline): may affect bleeding patterns.
• Herbal supplements (e.g., St John’s wort): may diminish efficacy.